Lim, B.; Peterson, C.B.; Davis, A.; Cho, E.; Pearson, T.; Liu, H.; Hwang, M.; Ueno, N.T.; Lee, J.
ONC201 and an MEK Inhibitor Trametinib Synergistically Inhibit the Growth of Triple-Negative Breast Cancer Cells. Biomedicines 2021, 9, 1410.
https://doi.org/10.3390/biomedicines9101410
AMA Style
Lim B, Peterson CB, Davis A, Cho E, Pearson T, Liu H, Hwang M, Ueno NT, Lee J.
ONC201 and an MEK Inhibitor Trametinib Synergistically Inhibit the Growth of Triple-Negative Breast Cancer Cells. Biomedicines. 2021; 9(10):1410.
https://doi.org/10.3390/biomedicines9101410
Chicago/Turabian Style
Lim, Bora, Christine B. Peterson, Alexander Davis, Elin Cho, Troy Pearson, Huey Liu, Minha Hwang, Naoto Tada Ueno, and Jangsoon Lee.
2021. "ONC201 and an MEK Inhibitor Trametinib Synergistically Inhibit the Growth of Triple-Negative Breast Cancer Cells" Biomedicines 9, no. 10: 1410.
https://doi.org/10.3390/biomedicines9101410
APA Style
Lim, B., Peterson, C. B., Davis, A., Cho, E., Pearson, T., Liu, H., Hwang, M., Ueno, N. T., & Lee, J.
(2021). ONC201 and an MEK Inhibitor Trametinib Synergistically Inhibit the Growth of Triple-Negative Breast Cancer Cells. Biomedicines, 9(10), 1410.
https://doi.org/10.3390/biomedicines9101410